WISP3 suppresses ESCC progression by inhibiting the IGF-2-IGF1R-AKT signaling cascade

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Esophageal squamous cell carcinoma (ESCC) poses a significant global health challenge, particularly in China.
• The underlying molecular mechanisms driving ESCC progression remain largely unknown.
• Identifying key genes involved in ESCC is crucial for developing effective treatments.

Purpose of the Study:

• To investigate the role of WISP3 in the development and progression of ESCC.
• To elucidate the molecular mechanisms by which WISP3 influences ESCC.
• To evaluate WISP3 as a potential therapeutic target for ESCC.

Main Methods:

• Quantitative analysis of WISP3 expression in ESCC tissues versus normal esophageal epithelium.
• In vitro studies using ESCC cell lines to assess the effects of WISP3 modulation on proliferation and migration.
• In vivo experiments to evaluate the impact of WISP3 on tumor growth and metastasis.
• Investigation of the signaling pathways affected by WISP3, including AKT and the IGF-2-IGF1R cascade.

Main Results:

• WISP3 expression is significantly downregulated in ESCC tissues, correlating with poorer patient survival.
• Overexpression of WISP3 inhibits ESCC cell proliferation, migration, tumor growth, and metastasis.
• WISP3 depletion enhances the tumorigenicity of ESCC cells.
• WISP3 exerts its tumor-suppressive effects by inhibiting the AKT pathway via the IGF-2-IGF1R signaling cascade.

Conclusions:

• WISP3 acts as a tumor suppressor in esophageal squamous cell carcinoma.
• WISP3 downregulation is a key event in ESCC development.
• Targeting WISP3 or its associated signaling pathways presents a promising therapeutic avenue for ESCC treatment.